US 11993644
Antigen binding molecules targeting SARS-CoV-2
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11993644 (Antigen binding molecules targeting SARS-CoV-2) held by Generate Biomedicines, Inc. expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Generate Biomedicines, Inc.
- Grant date
- Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/13, A61K31/215